US20200118468A1 - Intravenous bag and line label - Google Patents
Intravenous bag and line label Download PDFInfo
- Publication number
- US20200118468A1 US20200118468A1 US16/707,364 US201916707364A US2020118468A1 US 20200118468 A1 US20200118468 A1 US 20200118468A1 US 201916707364 A US201916707364 A US 201916707364A US 2020118468 A1 US2020118468 A1 US 2020118468A1
- Authority
- US
- United States
- Prior art keywords
- intravenous
- label
- solution
- line
- intravenous line
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000001990 intravenous administration Methods 0.000 title claims abstract description 224
- 239000000853 adhesive Substances 0.000 claims abstract description 14
- 230000001070 adhesive effect Effects 0.000 claims abstract description 14
- 238000004891 communication Methods 0.000 claims abstract description 4
- 239000012530 fluid Substances 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 16
- 238000002372 labelling Methods 0.000 claims description 7
- 238000010276 construction Methods 0.000 abstract description 49
- 229940079593 drug Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 238000002845 discoloration Methods 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- -1 compounded drugs Chemical class 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
- G09F3/00—Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps
- G09F3/08—Fastening or securing by means not forming part of the material of the label itself
- G09F3/10—Fastening or securing by means not forming part of the material of the label itself by an adhesive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/1414—Hanging-up devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B1/00—Layered products having a non-planar shape
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B3/00—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form
- B32B3/02—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by features of form at particular places, e.g. in edge regions
- B32B3/04—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by features of form at particular places, e.g. in edge regions characterised by at least one layer folded at the edge, e.g. over another layer ; characterised by at least one layer enveloping or enclosing a material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B3/00—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form
- B32B3/02—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by features of form at particular places, e.g. in edge regions
- B32B3/08—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by features of form at particular places, e.g. in edge regions characterised by added members at particular parts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B3/00—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form
- B32B3/10—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by a discontinuous layer, i.e. formed of separate pieces of material
- B32B3/18—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by a discontinuous layer, i.e. formed of separate pieces of material characterised by an internal layer formed of separate pieces of material which are juxtaposed side-by-side
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B3/00—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form
- B32B3/26—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by a particular shape of the outline of the cross-section of a continuous layer; characterised by a layer with cavities or internal voids ; characterised by an apertured layer
- B32B3/266—Layered products comprising a layer with external or internal discontinuities or unevennesses, or a layer of non-planar shape; Layered products comprising a layer having particular features of form characterised by a particular shape of the outline of the cross-section of a continuous layer; characterised by a layer with cavities or internal voids ; characterised by an apertured layer characterised by an apertured layer, the apertures going through the whole thickness of the layer, e.g. expanded metal, perforated layer, slit layer regular cells B32B3/12
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B7/00—Layered products characterised by the relation between layers; Layered products characterised by the relative orientation of features between layers, or by the relative values of a measurable parameter between layers, i.e. products comprising layers having different physical, chemical or physicochemical properties; Layered products characterised by the interconnection of layers
- B32B7/04—Interconnection of layers
- B32B7/06—Interconnection of layers permitting easy separation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B7/00—Layered products characterised by the relation between layers; Layered products characterised by the relative orientation of features between layers, or by the relative values of a measurable parameter between layers, i.e. products comprising layers having different physical, chemical or physicochemical properties; Layered products characterised by the interconnection of layers
- B32B7/04—Interconnection of layers
- B32B7/12—Interconnection of layers using interposed adhesives or interposed materials with bonding properties
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
- G09F3/00—Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps
- G09F3/02—Forms or constructions
- G09F3/0288—Labels or tickets consisting of more than one part, e.g. with address of sender or other reference on separate section to main label; Multi-copy labels
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
- G09F3/00—Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps
- G09F3/02—Forms or constructions
- G09F3/0295—Labels or tickets for tubes, pipes and the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/10—Bar codes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/20—Colour codes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/30—Printed labels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J2205/00—General identification or selection means
- A61J2205/60—General identification or selection means using magnetic or electronic identifications, e.g. chips, RFID, electronic tags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6009—General characteristics of the apparatus with identification means for matching patient with his treatment, e.g. to improve transfusion security
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6063—Optical identification systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2250/00—Layers arrangement
- B32B2250/02—2 layers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2307/00—Properties of the layers or laminate
- B32B2307/40—Properties of the layers or laminate having particular optical properties
- B32B2307/402—Coloured
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2307/00—Properties of the layers or laminate
- B32B2307/70—Other properties
- B32B2307/748—Releasability
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2519/00—Labels, badges
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
- G09F3/00—Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps
- G09F3/02—Forms or constructions
- G09F2003/0201—Label sheets intended to be introduced in a printer, e.g. laser printer
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
- G09F3/00—Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps
- G09F3/02—Forms or constructions
- G09F2003/0222—Features for removal or adhesion, e.g. tabs
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
- G09F3/00—Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps
- G09F3/02—Forms or constructions
- G09F2003/0225—Carrier web
- G09F2003/0229—Carrier roll
-
- G—PHYSICS
- G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
- G09F—DISPLAYING; ADVERTISING; SIGNS; LABELS OR NAME-PLATES; SEALS
- G09F3/00—Labels, tag tickets, or similar identification or indication means; Seals; Postage or like stamps
- G09F3/02—Forms or constructions
- G09F2003/0264—Shapes or borders
- G09F2003/0269—Shapes or borders perforated
Definitions
- the present disclosure relates to a system for ensuring accuracy of printed labels for intravenous bags and for intravenous lines engaged with the intravenous bags.
- solutions such as diluent solutions, such as saline solutions or dextrose solutions, or solutions including pharmaceutical compounds, such as compounded drugs, may be administered to a patient intravenously.
- a solution to be administered intravenously is packaged within an intravenous bag and dispensed to the patient through an intravenous line engaged with the intravenous bag.
- Intravenous bags are typically labeled with information identifying a name of the solution, for example a name of the diluent or a name of the pharmaceutical compound in the solution.
- Color-coded labels, color-coded risk indicators, and TALLman letters are often used to assist healthcare professionals in quickly and accurately identifying the solution dispensed from each of the intravenous bags.
- a patient may be simultaneously treated with multiple intravenously-delivered solutions.
- Each solution is delivered from an intravenous bag through a dedicated intravenous line.
- the intravenous lines engaged with the intravenous bags are often also labeled with the name of the solution to avoid confusion between lines from different bags, for example when changing intravenous bags or inspecting intravenous lines.
- the intravenous line labels are typically provided separately from the intravenous bag labels, which could lead to mislabeling of the intravenous line.
- the intravenous line label may block the labeled portion of the intravenous line, preventing a healthcare provider from noticing air bubbles, discoloration, blockages, or other abnormalities present in the labeled portion of the intravenous line.
- the present disclosure relates to a labeling system that reduces the likelihood of label printing errors and mismatched intravenous bag and intravenous line labels.
- the labeling system of the present disclosure provides a label in which a bag label portion and a line label portion are printed onto a shared backing.
- the bag label portion is fixed to the shared backing and the line label portion is removably attached to the shared backing, enabling the line label to be removed from the liner and secured to an intravenous bag as a single unit.
- the removable intravenous line label may also include an opening that allows visualization of the labeled portion of the intravenous line. This opening enables a healthcare provider to inspect the labeled intravenous line at the point of attachment of the line label for air bubbles, discoloration, blockages, or other issues in the fluid flowing through the labeled portion of the intravenous line.
- the disclosure provides a label for use with an intravenous bag having a surface and an interior volume for holding a solution.
- the intravenous bag is in fluid communication with an intravenous line for dispensing the solution.
- the label includes a back layer including an adhesive for securing the label to a surface of the intravenous bag.
- the label further includes a front layer including a first portion secured to the back layer and including a solution name.
- the front label in turn includes a second portion removable from the back layer and engageable with the intravenous line.
- the second portion includes the solution name on a first side and a second side.
- the solution name on the second side is inverted with respect to the solution name on the first side.
- the second portion may also include an opening for viewing a portion of the intravenous line when the second portion is engaged with the intravenous line.
- the solution name on the second side is not inverted with respect to the solution name on the first side.
- the disclosure provides an intravenous solution delivery system including an intravenous bag having a surface and an interior volume adapted to receive a solution.
- the intravenous solution delivery system also includes an intravenous line engaged with the intravenous bag for dispensing the solution.
- the intravenous solution delivery system further includes a label attached to the intravenous bag.
- the label includes a back layer having an adhesive for securing the label to a surface of the intravenous bag.
- the label further includes a front layer including a first portion secured to the back layer and including a solution name.
- the front layer further includes a second portion removable from the back layer and engageable with the intravenous line.
- the second portion includes the solution name on a first side and a second side.
- the solution name on the second side is inverted with respect to the solution name on the first side.
- the second portion may also include an opening for viewing a portion of the intravenous line when the second portion is engaged with the intravenous line.
- the solution name on the second side is not inverted with respect to the solution name on the first side.
- the disclosure provides a method of labeling an intravenous line engaged with an intravenous bag including a surface and defining an interior volume for receiving a solution.
- the method includes providing a label including a back layer including an adhesive for securing the label to a surface of the intravenous bag a front layer including a first portion secured to the back layer and including a solution name.
- the front layer further includes a second portion removable from the back layer and engageable with the intravenous line.
- the second portion has the solution name on a first side and a second side.
- the solution name on the second side is inverted with respect to the solution name on the first side.
- the second portion may also include an opening for viewing a portion of the intravenous line when the second portion is engaged with the intravenous line.
- the method further includes engaging the label with the surface of the intravenous bag; detaching the second portion of the label from the first portion of the label; aligning the opening of the second portion along the intravenous line; and folding the second portion about the intravenous line to secure the second side to the first side so that the first side and the second side display the name of the solution.
- the disclosure provides a method of printing an intravenous bag label for use with an intravenous bag engageable with an intravenous line.
- the method includes selecting a solution name from a solution information database stored in a memory of a label printer.
- the method further includes retrieving printing instructions from the solution information database.
- the printing instructions include a type of a roll of labels upon which to print the solution name.
- the method further includes aligning the roll of labels with a printing member of the label printer.
- the roll of labels includes a backing sheet having a machine-readable label including a type of the roll of labels.
- the method further includes scanning the machine-readable label on the roll of labels to confirm the type of the roll of labels.
- the method further includes printing at least one label of the roll of labels according to the printing instructions.
- FIG. 1 is a perspective view of an intravenous bag labeling system engaged with an intravenous bag.
- FIG. 2 is a view of a portion of a roll of intravenous bag labels that includes the intravenous bag labels of FIG. 1 before printing according to one construction.
- FIG. 3 is an exploded view of the intravenous bag label of FIG. 2 .
- FIG. 4 is a detail view of a line label portion of the intravenous bag label of FIG. 2 according to one construction.
- FIG. 5 is a detail view of a line label portion of the intravenous bag label of FIG. 2 according to another construction.
- FIG. 6 is a detail view of a line label portion the intravenous bag label of FIG. 2 according to another construction.
- FIG. 7 is a perspective view of an intravenous line portion of the intravenous bag label of FIG. 2 aligned with an intravenous line.
- FIG. 8 is a perspective view of an intravenous line portion of the intravenous bag label of FIG. 2 engaged with an intravenous line.
- FIG. 9 is a schematic representation of a printing machine for printing the intravenous bag label of FIG. 2 according to some constructions.
- FIG. 1 illustrates an intravenous bag 10 that includes an intravenous bag label 14 , a hanger hole 18 , an internal volume 22 , a medication port 26 , and an intravenous line port 30 .
- the intravenous bag label 14 includes a bag label 34 and a line label 38 .
- the intravenous bag label 14 is mounted on a front face 42 of the intravenous bag 10 .
- a similar or identical label may be attached to the back face (not shown) of the intravenous bag 10 .
- the hanger hole 18 is positioned proximate a top of the intravenous bag 10 for mounting the intravenous bag 10 on an intravenous bag pole (not shown).
- the internal volume 22 receives a solution for administration to a patient.
- the medication port 26 is positioned proximate a bottom of the intravenous bag 10 .
- the medication port 26 allows a healthcare provider to add medication to the solution inside the internal volume 22 .
- the intravenous line port 30 is positioned proximate the bottom of the intravenous bag 10 .
- the intravenous line port 30 receives an intravenous line 46 for administering the solution to the patient.
- the bag label 34 may include an upper portion 50 and a lower portion 54 .
- the upper portion 50 of the bag label 34 and/or the intravenous line label 38 may be color-coded to assist a user in identifying the solution stored in the intravenous bag 10 .
- the upper portion 50 may also include information such as a name 58 of the solution, a total dose of the solution, or a concentration of the solution, and a total volume of the solution.
- the lower portion 54 may include a risk indicator 62 to alert a user to a risk characteristic of the drug, such as the “high alert” indicator 62 shown positioned beneath the upper portion 50 in FIG. 1 .
- the label lower portion 54 may also include identifying information such as a lot number of the solution, a packaging date of the solution, and an expiration date of the solution.
- the lower portion 54 may also include a machine-readable label 66 that includes identifying information about the solution stored in the intravenous bag 10 .
- Exemplary identifying information may include the name 58 of the solution, the dose or the composition of the solution, the total volume of the solution, the lot number of the solution, the expiration date of the solution, and/or the packing date of the solution.
- the machine-readable label 66 is a barcode.
- the machine-readable label 66 may be an RFID tag embedded in the intravenous bag label 14 .
- the intravenous bag label 14 may be made from a material that may be written-upon by a user.
- the bag label 34 is attached to a carrier sheet 70 .
- the carrier sheet 70 is affixed to the front face 42 of the intravenous bag 10 with an adhesive (not shown) that ensures that the carrier sheet 70 cannot easily be removed from the intravenous bag 10 ( FIG. 1 ).
- the carrier sheet 70 is longer than the bag label 34 . Since the carrier sheet 70 is longer than the bag label 34 , a portion 74 of the carrier sheet 70 extends beyond an end 78 of the bag label 34 .
- the line label 38 may be attached to the portion 74 of the carrier sheet 70 that extends beyond the end 78 of the bag label 34 .
- the line label 38 may be removed from the portion 74 of the carrier sheet 70 without disturbing the bag label 34 when the intravenous bag labeling system 14 is secured to the intravenous bag 10 .
- the bag label 34 and the line label 38 may be separated by a slit 82 .
- the line label 38 may include a marking 106 (FIGS. 4-5) proximate the slit 82 to encourage a user to remove the line label 38 from the bag label 34 .
- the bag label 34 and the line label 38 are separated by a perforated line.
- at least some of the portion 74 of the carrier sheet 70 that extends beyond the end 78 of the bag label 34 may include a non-stick coating.
- the entire portion 74 includes a non-stick coating.
- the line label 38 includes a first portion 90 and a second portion 94 .
- the name 58 of the solution stored in the internal volume 22 of the intravenous bag 10 is printed on the front of the first portion 90 and the front of the second portion 94 .
- the name 58 printed on the second portion 94 is inverted with respect to the name 58 printed on the first portion 90 .
- the name 58 of the solution is therefore readable by a user from above or below the line label 38 when the line label 38 is engaged with the intravenous line 46 .
- FIG. 1 In some constructions, such as shown in FIG.
- the name 58 printed on the second portion 94 is not inverted with respect to the name 58 printed on the first portion 90 .
- At least a portion of the back of the first portion 90 or the back of the second portion 94 of the line label 38 includes an adhesive (not shown).
- the adhesive secures the back of the first portion 90 to the back of the second portion 94 .
- a portion of the adhesive may engage the intravenous line 46 to reduce slipping of the line label 38 along the intravenous line 46 .
- the removable line label 38 has rounded corners 98 to reduce possible patient discomfort should the label rub against a patient when the line label 38 is engaged with the intravenous line 46 .
- the rounded corners 98 of the line label 38 are formed by die-cutting.
- the line label 38 may be removed from the intravenous line 46 .
- a healthcare practitioner may tear the line label 38 off of the intravenous line 46 after the patient has stopped being treated with the solution in the intravenous bag 10 .
- the line label 38 may include an opening 102 .
- the opening 102 preferably has a width 108 longer than a circumference of the intravenous line 46 .
- the intravenous line 46 is therefore visible when the line label 38 is engaged with the intravenous line 46 .
- the opening 102 allows the user to check for air bubbles, discoloration, or any other abnormalities in the intravenous line 46 while the line label 38 is engaged with the intravenous line 46 .
- the opening 102 may be substantially centered along the line label 38 . In other constructions, the opening 102 may be off-center along the line label 38 . In the illustrated construction, the opening 102 is formed by die-cutting.
- the unitary construction of the intravenous bag label 14 enables the line label 38 to be printed at the same time as the bag label 34 is printed, which reduces the likelihood that the intravenous line 46 could be mislabeled.
- intravenous bag labels 14 that have not yet been printed with the solution name 58 may be provided on a backing sheet 118 .
- the backing sheet 118 may be rolled into a spool of unprinted intravenous bag labels 14 .
- the intravenous bag labels 14 may include color coding on the upper portion 50 , the lower portion 54 , and/or the risk indicator 62 printed on the lower portion 54 .
- the backing sheet 118 of each roll may include a machine-readable label 122 ( FIG. 2 ) that includes data about any color coding or indicia pre-printed on the intravenous bag labels 14 .
- the machine-readable label 122 is generally perpendicular to a longitudinal extent of the backing sheet 118 and offset from a center of a width of the backing sheet 118 .
- the machine-readable label 122 is printed on a front side (e.g. the side including the intravenous bag labels 14 ) of the backing sheet 118 .
- the machine-readable label may be printed on a back side of the backing sheet 118 .
- the machine-readable label 122 is a barcode including a roll stock number of the roll of intravenous bag labels 14 .
- the rolls of intravenous bag labels 14 may be used with the label printing machine 126 .
- the label printing machine 126 includes a control system 130 , a user interface 134 , a label reader 138 , and a printer 142 .
- the control system 130 is included the label printing machine 126 .
- the control system may be included in a computing device that is in electronic communication with the label printing machine.
- the control system 130 includes a processor 146 and a memory 150 .
- the memory 150 includes a solution information database 154 .
- the solution information database 154 includes information that must be printed on the intravenous bag labels 14 for each solution that could be stored in and dispensed from the intravenous bag 10 .
- the solution information database 154 may include information such as the name 58 of the drug or solution, the dose or the composition of the solution, the total volume of the solution, the expiration date of the solution, the lot number of the solution, and any other information required by labelling standards.
- the solution information database 154 may also include label printing instructions that may specify a specific color code or risk indicator 62 that must be included on the intravenous bag labels 14 .
- the label printing machine 126 is adapted to receive preprinted rolls of intravenous bag labels 14 that include color coding and alert indicia. The label printing machine 126 may also receive rolls of intravenous bag labels 14 that are not pre-printed with color coding or risk indicators 62 .
- a user verifies the solution name 58 for printing onto the intravenous bag label 14 or to print onto multiple intravenous bag labels 14 .
- the user enters the solution name 58 into user interface 134 of the label printing machine 126 , for example by scanning a machine-readable label including the solution name 58 and the barcode roll stock number 14 with the label reader 138 of the label printing machine 126 .
- the control system 130 retrieves the information that must be printed onto the intravenous bag label 14 from the solution information database 154 .
- the label reader 138 then reads the machine-readable label 122 printed on the backing sheet 118 to ensure that the correct roll of intravenous bag labels 14 has been aligned with the printer 142 .
- the machine-readable label 122 may also be scanned with a manual label reader (not shown) and a user may manually verify that the correct roll of intravenous bag labels 14 is being used.
- the printer 142 then prints the drug information onto the intravenous bag labels 14 .
- the label reader 138 periodically checks the machine-readable label 122 printed on the backing sheet 118 to verify that the correct roll of intravenous bag labels 14 is being is used. Since the bag label 34 and the line label 38 are formed of a unitary intravenous bag label 14 , both the bag label 34 and the line label 38 are printed at the same time. Accordingly, both the bag label 34 and the line label 38 include the name 58 of the same solution. In some constructions, the bag label 34 and the line label 38 may include other identifying information about the solution.
- the intravenous bag label 14 is removed from the backing sheet 118 (e.g. on a spool or on a sheet of labels) as a single unit.
- the intravenous bag label 14 is then secured to the face 42 of the intravenous bag 10 .
- the intravenous bag 10 has been filled with the same solution name as the solution name 58 printed on the intravenous bag label 14 .
- the intravenous bag 10 will be filled with the same solution as the solution name 58 printed on the intravenous bag label 14 .
- the internal volume 22 is then filled with the intravenous bag 10 with the solution that is printed on the intravenous bag label 14 .
- the filled and labeled intravenous bag 10 is bagged for transportation to an end user, such as a healthcare worker.
- a second intravenous line label 14 may be secured to the intravenous bag 10 , for example at a face on an opposite side of the intravenous bag 10 than the face 45 .
- the healthcare worker When the intravenous bag 10 is deployed by a healthcare worker for use with a patient, the healthcare worker secures an end of intravenous line 46 to the intravenous bag 10 .
- the healthcare worker then detaches the line label 38 from the bag label 34 by peeling the line label 38 away from the carrier sheet 70 along the slit 82 .
- the healthcare worker then aligns the central axis 110 of the line label 38 with the intravenous line 46 as is shown in FIG. 7 .
- the healthcare worker may position one of the intravenous bag labels 14 on a portion of the intravenous line 46 that is proximate the intravenous bag 10 and one of the intravenous bag labels 14 on a portion of the intravenous line 46 that is (or will be) proximate the patient.
- the healthcare worker then folds the line label 38 about the intravenous line 46 so that the adhesive secures the back surface of the first portion 90 to the back surface of the second portion 94 to secure the line label 38 to the intravenous line 46 .
- the line label 38 displays the name 58 of the solution on the intravenous line 46 .
- the healthcare worker may inspect the intravenous line 46 through the opening 102 .
- the healthcare worker may write upon on the intravenous bag label 14 .
- the healthcare worker may write a date and a time at which the intravenous treatment started upon the intravenous bag label 14 .
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Mechanical Engineering (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
A label for use with an intravenous bag having a surface and an interior volume for holding a solution in fluid communication with an intravenous line for dispensing the solution, where the label includes a back layer including an adhesive for securing the label to a surface of the intravenous bag, a front layer with a solution name including a first portion secured to the back layer, the front layer including a second portion removable from the back layer engageable with the intravenous line with the solution name on a first side and a second side. In some constructions, the solution name on the second side is inverted with respect to the solution name on the first side, and the second portion further includes an opening for viewing a portion of the intravenous line when the second portion is engaged with the intravenous line.
Description
- This application is a continuation of U.S. patent application Ser. No. 16/451,578, filed on Jun. 25, 2019, which is a divisional of U.S. patent application Ser. No. 16/053,091, filed on Aug. 2, 2018, issued as U.S. Pat. No. 10,373,530 on Aug. 6, 2019, which claims priority to U.S. Provisional Patent Application No. 62/539,199, filed on Jul. 31, 2017, the entire contents of each of which are fully incorporated herein by reference.
- The present disclosure relates to a system for ensuring accuracy of printed labels for intravenous bags and for intravenous lines engaged with the intravenous bags.
- In the healthcare industry, solutions, such as diluent solutions, such as saline solutions or dextrose solutions, or solutions including pharmaceutical compounds, such as compounded drugs, may be administered to a patient intravenously. A solution to be administered intravenously is packaged within an intravenous bag and dispensed to the patient through an intravenous line engaged with the intravenous bag.
- Intravenous bags are typically labeled with information identifying a name of the solution, for example a name of the diluent or a name of the pharmaceutical compound in the solution. Color-coded labels, color-coded risk indicators, and TALLman letters are often used to assist healthcare professionals in quickly and accurately identifying the solution dispensed from each of the intravenous bags.
- A patient may be simultaneously treated with multiple intravenously-delivered solutions. Each solution is delivered from an intravenous bag through a dedicated intravenous line. The intravenous lines engaged with the intravenous bags are often also labeled with the name of the solution to avoid confusion between lines from different bags, for example when changing intravenous bags or inspecting intravenous lines. However, the intravenous line labels are typically provided separately from the intravenous bag labels, which could lead to mislabeling of the intravenous line. Furthermore, the intravenous line label may block the labeled portion of the intravenous line, preventing a healthcare provider from noticing air bubbles, discoloration, blockages, or other abnormalities present in the labeled portion of the intravenous line.
- The present disclosure relates to a labeling system that reduces the likelihood of label printing errors and mismatched intravenous bag and intravenous line labels. The labeling system of the present disclosure provides a label in which a bag label portion and a line label portion are printed onto a shared backing. The bag label portion is fixed to the shared backing and the line label portion is removably attached to the shared backing, enabling the line label to be removed from the liner and secured to an intravenous bag as a single unit. The removable intravenous line label may also include an opening that allows visualization of the labeled portion of the intravenous line. This opening enables a healthcare provider to inspect the labeled intravenous line at the point of attachment of the line label for air bubbles, discoloration, blockages, or other issues in the fluid flowing through the labeled portion of the intravenous line.
- In one construction, the disclosure provides a label for use with an intravenous bag having a surface and an interior volume for holding a solution. The intravenous bag is in fluid communication with an intravenous line for dispensing the solution. The label includes a back layer including an adhesive for securing the label to a surface of the intravenous bag. The label further includes a front layer including a first portion secured to the back layer and including a solution name. The front label in turn includes a second portion removable from the back layer and engageable with the intravenous line. The second portion includes the solution name on a first side and a second side. The solution name on the second side is inverted with respect to the solution name on the first side. The second portion may also include an opening for viewing a portion of the intravenous line when the second portion is engaged with the intravenous line. In another construction, the solution name on the second side is not inverted with respect to the solution name on the first side.
- In another construction, the disclosure provides an intravenous solution delivery system including an intravenous bag having a surface and an interior volume adapted to receive a solution. The intravenous solution delivery system also includes an intravenous line engaged with the intravenous bag for dispensing the solution. The intravenous solution delivery system further includes a label attached to the intravenous bag. The label includes a back layer having an adhesive for securing the label to a surface of the intravenous bag. The label further includes a front layer including a first portion secured to the back layer and including a solution name. The front layer further includes a second portion removable from the back layer and engageable with the intravenous line. The second portion includes the solution name on a first side and a second side. The solution name on the second side is inverted with respect to the solution name on the first side. The second portion may also include an opening for viewing a portion of the intravenous line when the second portion is engaged with the intravenous line. In another construction, the solution name on the second side is not inverted with respect to the solution name on the first side.
- In another construction, the disclosure provides a method of labeling an intravenous line engaged with an intravenous bag including a surface and defining an interior volume for receiving a solution. The method includes providing a label including a back layer including an adhesive for securing the label to a surface of the intravenous bag a front layer including a first portion secured to the back layer and including a solution name. The front layer further includes a second portion removable from the back layer and engageable with the intravenous line. The second portion has the solution name on a first side and a second side. The solution name on the second side is inverted with respect to the solution name on the first side. The second portion may also include an opening for viewing a portion of the intravenous line when the second portion is engaged with the intravenous line. The method further includes engaging the label with the surface of the intravenous bag; detaching the second portion of the label from the first portion of the label; aligning the opening of the second portion along the intravenous line; and folding the second portion about the intravenous line to secure the second side to the first side so that the first side and the second side display the name of the solution.
- In another construction, the disclosure provides a method of printing an intravenous bag label for use with an intravenous bag engageable with an intravenous line. The method includes selecting a solution name from a solution information database stored in a memory of a label printer. In response to selecting the solution name, the method further includes retrieving printing instructions from the solution information database. The printing instructions include a type of a roll of labels upon which to print the solution name. The method further includes aligning the roll of labels with a printing member of the label printer. The roll of labels includes a backing sheet having a machine-readable label including a type of the roll of labels. The method further includes scanning the machine-readable label on the roll of labels to confirm the type of the roll of labels. The method further includes printing at least one label of the roll of labels according to the printing instructions.
- Other aspects of the disclosure will become apparent by consideration of the detailed description and accompanying drawings.
-
FIG. 1 is a perspective view of an intravenous bag labeling system engaged with an intravenous bag. -
FIG. 2 is a view of a portion of a roll of intravenous bag labels that includes the intravenous bag labels ofFIG. 1 before printing according to one construction. -
FIG. 3 is an exploded view of the intravenous bag label ofFIG. 2 . -
FIG. 4 is a detail view of a line label portion of the intravenous bag label ofFIG. 2 according to one construction. -
FIG. 5 is a detail view of a line label portion of the intravenous bag label ofFIG. 2 according to another construction. -
FIG. 6 is a detail view of a line label portion the intravenous bag label ofFIG. 2 according to another construction. -
FIG. 7 is a perspective view of an intravenous line portion of the intravenous bag label ofFIG. 2 aligned with an intravenous line. -
FIG. 8 is a perspective view of an intravenous line portion of the intravenous bag label ofFIG. 2 engaged with an intravenous line. -
FIG. 9 is a schematic representation of a printing machine for printing the intravenous bag label ofFIG. 2 according to some constructions. - Before any constructions of the disclosure are explained in detail, it is to be understood that the disclosure is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the following drawings. The disclosure is capable of other constructions and of being practiced or of being carried out in various ways. In any disclosed construction, the term “approximately” may be substituted with “within a percentage of” what is specified, wherein the percentage includes 0.1, 1, 5, and 10 percent.
-
FIG. 1 illustrates anintravenous bag 10 that includes anintravenous bag label 14, ahanger hole 18, aninternal volume 22, amedication port 26, and anintravenous line port 30. Theintravenous bag label 14 includes abag label 34 and aline label 38. In the illustrated construction, theintravenous bag label 14 is mounted on afront face 42 of theintravenous bag 10. A similar or identical label may be attached to the back face (not shown) of theintravenous bag 10. Thehanger hole 18 is positioned proximate a top of theintravenous bag 10 for mounting theintravenous bag 10 on an intravenous bag pole (not shown). Theinternal volume 22 receives a solution for administration to a patient. Themedication port 26 is positioned proximate a bottom of theintravenous bag 10. Themedication port 26 allows a healthcare provider to add medication to the solution inside theinternal volume 22. Theintravenous line port 30 is positioned proximate the bottom of theintravenous bag 10. Theintravenous line port 30 receives anintravenous line 46 for administering the solution to the patient. - As shown in
FIGS. 1 and 2 , thebag label 34 may include anupper portion 50 and alower portion 54. Theupper portion 50 of thebag label 34 and/or theintravenous line label 38 may be color-coded to assist a user in identifying the solution stored in theintravenous bag 10. Theupper portion 50 may also include information such as aname 58 of the solution, a total dose of the solution, or a concentration of the solution, and a total volume of the solution. Thelower portion 54 may include arisk indicator 62 to alert a user to a risk characteristic of the drug, such as the “high alert”indicator 62 shown positioned beneath theupper portion 50 inFIG. 1 . The labellower portion 54 may also include identifying information such as a lot number of the solution, a packaging date of the solution, and an expiration date of the solution. Thelower portion 54 may also include a machine-readable label 66 that includes identifying information about the solution stored in theintravenous bag 10. Exemplary identifying information may include thename 58 of the solution, the dose or the composition of the solution, the total volume of the solution, the lot number of the solution, the expiration date of the solution, and/or the packing date of the solution. In the construction illustrated inFIG. 1 , the machine-readable label 66 is a barcode. In other constructions, the machine-readable label 66 may be an RFID tag embedded in theintravenous bag label 14. In some constructions, theintravenous bag label 14 may be made from a material that may be written-upon by a user. - As illustrated in
FIG. 3 , thebag label 34 is attached to acarrier sheet 70. Thecarrier sheet 70 is affixed to thefront face 42 of theintravenous bag 10 with an adhesive (not shown) that ensures that thecarrier sheet 70 cannot easily be removed from the intravenous bag 10 (FIG. 1 ). Thecarrier sheet 70 is longer than thebag label 34. Since thecarrier sheet 70 is longer than thebag label 34, aportion 74 of thecarrier sheet 70 extends beyond anend 78 of thebag label 34. Theline label 38 may be attached to theportion 74 of thecarrier sheet 70 that extends beyond theend 78 of thebag label 34. Theline label 38 may be removed from theportion 74 of thecarrier sheet 70 without disturbing thebag label 34 when the intravenousbag labeling system 14 is secured to theintravenous bag 10. In the illustrated construction, thebag label 34 and theline label 38 may be separated by aslit 82. Theline label 38 may include a marking 106 (FIGS. 4-5) proximate theslit 82 to encourage a user to remove theline label 38 from thebag label 34. In other constructions, thebag label 34 and theline label 38 are separated by a perforated line. To facilitate removal of theline label 38, in some constructions, at least some of theportion 74 of thecarrier sheet 70 that extends beyond theend 78 of thebag label 34 may include a non-stick coating. In some constructions, theentire portion 74 includes a non-stick coating. - As is best shown in
FIGS. 4-6 , theline label 38 includes afirst portion 90 and asecond portion 94. Thename 58 of the solution stored in theinternal volume 22 of theintravenous bag 10 is printed on the front of thefirst portion 90 and the front of thesecond portion 94. In the construction illustrated inFIGS. 4 and 5 , thename 58 printed on thesecond portion 94 is inverted with respect to thename 58 printed on thefirst portion 90. Thename 58 of the solution is therefore readable by a user from above or below theline label 38 when theline label 38 is engaged with theintravenous line 46. In some constructions, such as shown inFIG. 6 , thename 58 printed on thesecond portion 94 is not inverted with respect to thename 58 printed on thefirst portion 90. At least a portion of the back of thefirst portion 90 or the back of thesecond portion 94 of theline label 38 includes an adhesive (not shown). When theline label 38 is secured to the intravenous line 46 (FIG. 8 ), the adhesive secures the back of thefirst portion 90 to the back of thesecond portion 94. A portion of the adhesive may engage theintravenous line 46 to reduce slipping of theline label 38 along theintravenous line 46. As is best shown inFIGS. 4-8 , theremovable line label 38 has roundedcorners 98 to reduce possible patient discomfort should the label rub against a patient when theline label 38 is engaged with theintravenous line 46. In the illustrated construction, therounded corners 98 of theline label 38 are formed by die-cutting. In some constructions, acentral axis 110 of theopening 102 shown with aline 114 positioned to assist a user in aligning theline label 38 with theintravenous line 46. Theline label 38 may be removed from theintravenous line 46. For example, a healthcare practitioner may tear theline label 38 off of theintravenous line 46 after the patient has stopped being treated with the solution in theintravenous bag 10. - In some constructions, such as the constructions of
FIGS. 4 and 6-8 , theline label 38 may include anopening 102. Theopening 102 preferably has awidth 108 longer than a circumference of theintravenous line 46. Theintravenous line 46 is therefore visible when theline label 38 is engaged with theintravenous line 46. Theopening 102 allows the user to check for air bubbles, discoloration, or any other abnormalities in theintravenous line 46 while theline label 38 is engaged with theintravenous line 46. As shown inFIG. 4 , theopening 102 may be substantially centered along theline label 38. In other constructions, theopening 102 may be off-center along theline label 38. In the illustrated construction, theopening 102 is formed by die-cutting. - Referring again to
FIG. 2 , the unitary construction of theintravenous bag label 14 enables theline label 38 to be printed at the same time as thebag label 34 is printed, which reduces the likelihood that theintravenous line 46 could be mislabeled. In constructions in which theintravenous bag label 14 is printed using alabel printing machine 126, intravenous bag labels 14 that have not yet been printed with thesolution name 58 may be provided on abacking sheet 118. Thebacking sheet 118 may be rolled into a spool of unprinted intravenous bag labels 14. The intravenous bag labels 14 may include color coding on theupper portion 50, thelower portion 54, and/or therisk indicator 62 printed on thelower portion 54. Thebacking sheet 118 of each roll may include a machine-readable label 122 (FIG. 2 ) that includes data about any color coding or indicia pre-printed on the intravenous bag labels 14. In the illustrated construction, the machine-readable label 122 is generally perpendicular to a longitudinal extent of thebacking sheet 118 and offset from a center of a width of thebacking sheet 118. In the illustrated construction, the machine-readable label 122 is printed on a front side (e.g. the side including the intravenous bag labels 14) of thebacking sheet 118. In other constructions, the machine-readable label may be printed on a back side of thebacking sheet 118. In the illustrated construction, the machine-readable label 122 is a barcode including a roll stock number of the roll of intravenous bag labels 14. The rolls of intravenous bag labels 14 may be used with thelabel printing machine 126. - With reference to
FIG. 9 , thelabel printing machine 126 includes acontrol system 130, a user interface 134, alabel reader 138, and aprinter 142. In some constructions, thecontrol system 130 is included thelabel printing machine 126. In other constructions, the control system may be included in a computing device that is in electronic communication with the label printing machine. Thecontrol system 130 includes aprocessor 146 and amemory 150. Thememory 150 includes asolution information database 154. Thesolution information database 154 includes information that must be printed on the intravenous bag labels 14 for each solution that could be stored in and dispensed from theintravenous bag 10. For example, thesolution information database 154 may include information such as thename 58 of the drug or solution, the dose or the composition of the solution, the total volume of the solution, the expiration date of the solution, the lot number of the solution, and any other information required by labelling standards. Thesolution information database 154 may also include label printing instructions that may specify a specific color code orrisk indicator 62 that must be included on the intravenous bag labels 14. In the illustrated construction, thelabel printing machine 126 is adapted to receive preprinted rolls of intravenous bag labels 14 that include color coding and alert indicia. Thelabel printing machine 126 may also receive rolls of intravenous bag labels 14 that are not pre-printed with color coding orrisk indicators 62. - In operation, a user verifies the
solution name 58 for printing onto theintravenous bag label 14 or to print onto multiple intravenous bag labels 14. The user enters thesolution name 58 into user interface 134 of thelabel printing machine 126, for example by scanning a machine-readable label including thesolution name 58 and the barcoderoll stock number 14 with thelabel reader 138 of thelabel printing machine 126. In response to receiving thesolution name 58, thecontrol system 130 retrieves the information that must be printed onto theintravenous bag label 14 from thesolution information database 154. Thelabel reader 138 then reads the machine-readable label 122 printed on thebacking sheet 118 to ensure that the correct roll of intravenous bag labels 14 has been aligned with theprinter 142. The machine-readable label 122 may also be scanned with a manual label reader (not shown) and a user may manually verify that the correct roll of intravenous bag labels 14 is being used. Theprinter 142 then prints the drug information onto the intravenous bag labels 14. In some constructions, thelabel reader 138 periodically checks the machine-readable label 122 printed on thebacking sheet 118 to verify that the correct roll of intravenous bag labels 14 is being is used. Since thebag label 34 and theline label 38 are formed of a unitaryintravenous bag label 14, both thebag label 34 and theline label 38 are printed at the same time. Accordingly, both thebag label 34 and theline label 38 include thename 58 of the same solution. In some constructions, thebag label 34 and theline label 38 may include other identifying information about the solution. - In operation, the
intravenous bag label 14 is removed from the backing sheet 118 (e.g. on a spool or on a sheet of labels) as a single unit. Theintravenous bag label 14 is then secured to theface 42 of theintravenous bag 10. In some constructions, theintravenous bag 10 has been filled with the same solution name as thesolution name 58 printed on theintravenous bag label 14. In other constructions, theintravenous bag 10 will be filled with the same solution as thesolution name 58 printed on theintravenous bag label 14. Theinternal volume 22 is then filled with theintravenous bag 10 with the solution that is printed on theintravenous bag label 14. The filled and labeledintravenous bag 10 is bagged for transportation to an end user, such as a healthcare worker. In some constructions, a secondintravenous line label 14 may be secured to theintravenous bag 10, for example at a face on an opposite side of theintravenous bag 10 than the face 45. - When the
intravenous bag 10 is deployed by a healthcare worker for use with a patient, the healthcare worker secures an end ofintravenous line 46 to theintravenous bag 10. The healthcare worker then detaches theline label 38 from thebag label 34 by peeling theline label 38 away from thecarrier sheet 70 along theslit 82. The healthcare worker then aligns thecentral axis 110 of theline label 38 with theintravenous line 46 as is shown inFIG. 7 . In constructions in which two intravenous line labels 14 are secured to theintravenous bag 10, the healthcare worker may position one of the intravenous bag labels 14 on a portion of theintravenous line 46 that is proximate theintravenous bag 10 and one of the intravenous bag labels 14 on a portion of theintravenous line 46 that is (or will be) proximate the patient. The healthcare worker then folds theline label 38 about theintravenous line 46 so that the adhesive secures the back surface of thefirst portion 90 to the back surface of thesecond portion 94 to secure theline label 38 to theintravenous line 46. When theline label 38 is secured to theintravenous line 46, theline label 38 displays thename 58 of the solution on theintravenous line 46. In constructions having theopening 102, the healthcare worker may inspect theintravenous line 46 through theopening 102. In constructions in which theintravenous bag label 14 is made by a material that may be written upon, the healthcare worker may write upon on theintravenous bag label 14. For example, the healthcare worker may write a date and a time at which the intravenous treatment started upon theintravenous bag label 14. - Various features and advantages of the disclosure are set forth in the following claims.
Claims (19)
1. A label for use with an intravenous bag having a surface and an interior volume for holding a solution in fluid communication with an intravenous line for dispensing the solution, the label comprising:
a back layer including an adhesive for securing the label to a surface of the intravenous bag; and
a front layer including:
a first portion secured to the back layer displaying a solution name, and
a second portion removable from the back layer and engageable with the intravenous line, the second portion including the solution name on a first side and a second side, the solution name on the second side inverted with respect to the solution name on the first side, and an opening for viewing a portion of the intravenous line when the second portion is engaged with the intravenous line.
2. The label of claim 1 , wherein the second portion is foldable about the intravenous line to secure the second portion to the intravenous line and wherein the first side and the second side display the solution name when the second portion is engaged with the intravenous line.
3. The label of claim 1 , wherein at least a portion of a back of the second portion has an adhesive proximate the opening.
4. The label of claim 1 , wherein the second portion has rounded corners.
5. The label of claim 1 , wherein the opening has a width that is larger than a circumference of the intravenous line.
6. The intravenous solution delivery system of claim 5 , wherein a portion of the intravenous line is visible through the opening when the second portion is positioned along the intravenous line.
7. The label of claim 1 , wherein a slit is formed between the first portion and the second portion.
8. An intravenous solution delivery system comprising:
an intravenous bag including a surface and an interior volume adapted to receive a solution;
an intravenous line engaged with the intravenous bag and configured to dispense the solution;
a label attached to the intravenous bag, the label including:
a back layer including an adhesive for securing the label to a surface of the intravenous bag; and
a front layer including:
a first portion secured to the back layer and including a solution name, and
a second portion removable from the back layer and engageable with the intravenous line, the second portion including the solution name on a first side and a second side, the solution name on the second side inverted with respect to the solution name on the first side, and an opening for viewing a portion of the intravenous line when the second portion is engaged with the intravenous line.
9. The intravenous solution delivery system of claim 8 , wherein the second portion is foldable about the intravenous line to secure the second portion to the intravenous line and the first side and the second side display the name of the solution when the second portion is engaged with the intravenous line.
10. The intravenous solution delivery system of claim 8 , wherein a width of the opening is larger than a circumference of the intravenous line.
11. The intravenous solution delivery system of claim 10 , wherein a portion of the intravenous line is visible through the opening when the second portion is positioned along the intravenous line.
12. The intravenous solution delivery system of claim 8 , wherein a perforated line is formed between the first portion and the second portion.
13. A method of labeling an intravenous line engaged with an intravenous bag including a surface and defining an interior volume for receiving a solution, the method comprising:
providing a label including:
a back layer including an adhesive for securing the label to a surface of the intravenous bag; and
a front layer including:
a first portion secured to the back layer and including a solution name, and
a second portion removable from the back layer and engageable with the intravenous line, the second portion including the solution name on a first side and a second side, the solution name on the second side inverted with respect to the solution name on the first side, and an opening for viewing a portion of the intravenous line when the second portion is engaged with the intravenous line, engaging the label with the surface of the intravenous bag;
detaching the second portion of the label from the first portion of the label;
aligning the opening of the second portion along the intravenous line; and
folding the second portion about the intravenous line to secure the second side to the first side so that the first side and the second side display the name of the solution.
14. The label of claim 13 , further comprising the step of viewing a portion of the intravenous line through the opening when the second portion is positioned along the intravenous line.
15. A method of printing an intravenous bag label for use with an intravenous bag engageable with an intravenous line comprising:
selecting with a user interface a solution name from a solution information database stored in a memory a control system;
responsive to selecting the solution name, retrieving printing instructions from the solution information database, the printing instructions including the identification of a type of a roll of labels upon which to print the solution name and selecting the identified roll;
aligning the selected roll of labels with a printing member of the label printer, the roll of labels including a backing sheet having a machine-readable label identifying the type of the selected roll of labels;
scanning the machine-readable label on the roll of labels to confirm the type of the roll of labels; and
printing at least one label of the roll of labels according to the printing instructions.
16. The method of claim 15 , wherein the at least one label on the roll of labels includes:
a back layer including an adhesive for securing the label to a surface of the intravenous bag; and
a front layer including:
a first portion secured to the back layer and including a solution name, and
a second portion removable from the back layer and engageable with the intravenous line, the second portion including the solution name on a first side and a second side, the solution name on the second side inverted with respect to the solution name on the first side, and an opening for viewing a portion of the intravenous line when the second portion is engaged with the intravenous line.
17. The method of claim 15 , wherein the type of labels includes a color-coded upper portion.
18. The method of claim 15 , wherein the type of labels includes a risk indicator.
19. The method claim 15 , wherein the machine-readable label is off-center with respect to a backing of the roll of labels and generally parallel to a longitudinal extent of the backing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/707,364 US20200118468A1 (en) | 2017-07-31 | 2019-12-09 | Intravenous bag and line label |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762539199P | 2017-07-31 | 2017-07-31 | |
US16/053,091 US10373530B2 (en) | 2017-07-31 | 2018-08-02 | Intravenous bag and line label |
US16/451,578 US10504387B2 (en) | 2017-07-31 | 2019-06-25 | Intravenous bag and line label |
US16/707,364 US20200118468A1 (en) | 2017-07-31 | 2019-12-09 | Intravenous bag and line label |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/451,578 Continuation US10504387B2 (en) | 2017-07-31 | 2019-06-25 | Intravenous bag and line label |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200118468A1 true US20200118468A1 (en) | 2020-04-16 |
Family
ID=65038130
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/053,091 Active US10373530B2 (en) | 2017-07-31 | 2018-08-02 | Intravenous bag and line label |
US16/451,578 Active US10504387B2 (en) | 2017-07-31 | 2019-06-25 | Intravenous bag and line label |
US16/707,364 Abandoned US20200118468A1 (en) | 2017-07-31 | 2019-12-09 | Intravenous bag and line label |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/053,091 Active US10373530B2 (en) | 2017-07-31 | 2018-08-02 | Intravenous bag and line label |
US16/451,578 Active US10504387B2 (en) | 2017-07-31 | 2019-06-25 | Intravenous bag and line label |
Country Status (1)
Country | Link |
---|---|
US (3) | US10373530B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD892934S1 (en) * | 2018-03-14 | 2020-08-11 | Radiometer Medical Aps | Label |
USD913489S1 (en) * | 2018-07-11 | 2021-03-16 | Boehringer Ingelheim Animal Health USA Inc. | Bag |
US11077292B2 (en) * | 2018-08-29 | 2021-08-03 | Star Luminal LLC | System of medical indicators having multisensory, multipurpose and multifunctional features |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020056989A1 (en) * | 1998-04-02 | 2002-05-16 | Lewis-Leander | Medication i.v. warning label |
US8025314B2 (en) * | 2002-05-15 | 2011-09-27 | Target Brands, Inc. | Medication packaging and labeling system |
US7588193B2 (en) * | 2006-03-16 | 2009-09-15 | Fenwal, Inc. | Blood component container |
US7918830B2 (en) * | 2007-12-03 | 2011-04-05 | Pharmedium Services, Llc | Safety device for drug delivery devices and containers |
USD687894S1 (en) | 2012-01-17 | 2013-08-13 | Pharmedium Services, Llc | Intravenous bag/line safety label |
US8597271B2 (en) * | 2012-01-17 | 2013-12-03 | Pharmedium Services, Llc | Intravenous bag/line safety device |
US20150272828A1 (en) * | 2012-10-05 | 2015-10-01 | The Board Of Trustees Of The University Of Illinois | Intravenous bag labeling system |
US20140237873A1 (en) * | 2013-02-23 | 2014-08-28 | Enrique Garay-Marrero | Multi-Label Form for Prescription Delivery Process |
WO2015023818A1 (en) * | 2013-08-15 | 2015-02-19 | Kodak Alaris Inc. | System and method for determining receiver type in a thermal printer |
DK3256133T3 (en) * | 2015-02-13 | 2022-10-24 | Sun Pharmaceutical Ind Ltd | INTRAVENOUS INFUSION DOSAGE FORM |
WO2017095779A1 (en) * | 2015-12-01 | 2017-06-08 | Id Technology Llc | In-line lable applicator |
FR3060304A1 (en) * | 2016-12-21 | 2018-06-22 | Adhex Thechnologies | BLOOD POCKET LABEL AND BLOOD POCKET WITH SUCH A LABEL |
US20180225999A1 (en) * | 2017-02-09 | 2018-08-09 | Premier Print & Services Group, Inc. | Double-sided printable label system |
-
2018
- 2018-08-02 US US16/053,091 patent/US10373530B2/en active Active
-
2019
- 2019-06-25 US US16/451,578 patent/US10504387B2/en active Active
- 2019-12-09 US US16/707,364 patent/US20200118468A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US10504387B2 (en) | 2019-12-10 |
US20190311655A1 (en) | 2019-10-10 |
US10373530B2 (en) | 2019-08-06 |
US20190035310A1 (en) | 2019-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10504387B2 (en) | Intravenous bag and line label | |
US8939662B2 (en) | Method of forming double side extended tab label with verification of prescription information | |
US5328208A (en) | Pharmacy form and method | |
US7941949B2 (en) | Multi-flag label | |
US8858506B2 (en) | Safety device for drug delivery devices and containers | |
US6685227B2 (en) | Label, a label system and method | |
US7926851B2 (en) | Extended tab label with backing liner | |
KR100843728B1 (en) | Writing device for display members on drug carrier | |
US20030061750A1 (en) | Label for pharmaceutical prescriptions | |
WO2013039578A1 (en) | Label measurement system for a container | |
US8405875B2 (en) | Visibly-coded medication label and associated method, apparatus and computer program product for providing same | |
US20130025529A1 (en) | Illustrative Label Measurement System For A Container | |
JP4668282B2 (en) | Drug bottle system | |
US8365451B2 (en) | Multi-layer label for affixing to a curved surface, particularly to a cylindrical surface, of an object | |
US9758270B1 (en) | Overflow panel system for pharmaceutical container | |
US6056322A (en) | Combination sample medication payment check and medication prescription device | |
US9586712B1 (en) | Overflow panel system for pharmaceutical container | |
US6012740A (en) | Combination sample medication payment check and medication prescription device | |
US10464697B1 (en) | Method for labeling pharmaceutical container with color advertising | |
JP2004017999A (en) | Method for labeling medicine bottle | |
JP2009240471A (en) | Label for medication and its printing method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- INCOMPLETE APPLICATION (PRE-EXAMINATION) |